切换至 "中华医学电子期刊资源库"

中华肾病研究电子杂志 ›› 2015, Vol. 04 ›› Issue (03) : 137 -140. doi: 10.3877/cma.j.issn.2095-3216.2015.03.006

所属专题: 文献

专家论坛

血液透析患者血压控制目标与药物选择
伦立德1,(), 高卓1   
  1. 1. 100142 北京,空军总医院肾病科
  • 出版日期:2015-06-28
  • 通信作者: 伦立德

Target of blood pressure control and drug selection in patients with hemodialysis

Lide Lun1,(), Zhuo Gao1   

  1. 1. Department of Nephrology, Air Force General Hospital, Beijing 100142, China
  • Published:2015-06-28
  • Corresponding author: Lide Lun
  • About author:
    Corresponding author: Lun Lide, Email:
引用本文:

伦立德, 高卓. 血液透析患者血压控制目标与药物选择[J]. 中华肾病研究电子杂志, 2015, 04(03): 137-140.

Lide Lun, Zhuo Gao. Target of blood pressure control and drug selection in patients with hemodialysis[J]. Chinese Journal of Kidney Disease Investigation(Electronic Edition), 2015, 04(03): 137-140.

高血压是维持性血液透析患者的常见并发症。长期高血压与血液透析患者增加的死亡率密切相关。因此,血液透析患者的降压治疗在整体治疗中占有重要地位。目前血液透析患者高血压治疗的靶目标尚有争议,作者建议降压的靶目标应该个体化。选择合适的透析方式是降压治疗的重要手段,但多数血液透析患者需要服用两种或两种以上不同类别的降压药联合控制血压,合理选择降压药物至关重要。

Hypertension is a common complication in patients with maintenance hemodialysis.Long-term hypertension is closely related to increased mortality in patients undergoing hemodialysis. Hence, antihypertensive therapy plays an important role in the overall treatment. The target of antihypertensive therapy remains controversial. The author suggests that the target should be individualized. Selection of suitable dialysis modes is an important measure for anti-hypertension treatment. As most patients undergoing hemodialysis require two or more kinds of antihypertensive drugs to control blood pressure, reasonable choice of antihypertensive drugs is essential.

[1]
中国人民解放军肾脏病专业协作组.2001例血液透析患者病因分析及高血压和贫血治疗状况[J].中国血液净化,2005,4(5):235-238.
[2]
Li Z, Lacson E Jr, Lowrie EG,et al.The epidemiology of systolic b1ood pressure and death risk in hemodialysis patients [J].Am J Kidney Dis,2006,48(4):606-615.
[3]
Mitra S, Chandna SM, Farrington K. What is hypertension in chronic haemodialysis? The role of interdialytic blood pressure monitoring [J]. Nephro1 Dia1 Transplant, 1999, 14(12): 2915-2921.
[4]
陈香美,张利. 透析患者高血压的治疗策略:我们应从何处开始?[J]. 中国血液净化,2010,9(2):60-62.
[5]
Zager PG, Nikolic J, Brown TN,et al. "U" curve association of blood pressure and mortality in hemodialysis patients [J].Kidney Int,1998, 54(2):56l-569.
[6]
Port FK, Hulbert-Shearon TE, Wolfe RA, et al. Predialysis blood pressure and mortality risk in a national sample of maintenance hemodialysis patients [J].Am J Kidney Dis,1999,33(3):507-517.
[7]
Li Z, Lacson E Jr, Lowrie EG, et al.The epidemio1ogy of systolic b1ood pressure and death risk in hemodialysis patients [J].Am J Kidney Dis,2006,48(4):606-615.
[8]
Kalantar-Zadeh K, Kilpatrick RD, McA1lister CJ,et al. Reverse epidemiology of hypertension and cardiovascular death in the hemodialysis population:The 58th annual fal1 conference and scientific sessions [J].Hypertension,2005,45(4):811-817.
[9]
K/DOQI Workgroup.K/DOQI clinical practice guidelines for cardiovascular disease in dialysis patients [J].Am J Kidney Dis,2005,45(Suppl 3):S1-S153.
[10]
Kidney disease: improving global outcomes (KDIGO) blood pressure work group. KDIGO clinical practice guideline for the management of blood pressure in chronic kidney disease [J]. Kidney Inter Suppl, 2012, 2(5): 337-414.
[11]
Lacson EJ, Lazarus JM. The association between blood pressure and mortality in ESRD-not different from the general population[J]? Semin Dial,2007,20(6): 510-517.
[12]
Agarwal R1, Nissenson AR, Batlle D, et al. Prevalence, treatment, and control of hypertension in chronic hemodialysis patients in the United States [J]. Am J Med, 2003,115(4): 291-297.
[13]
Alborzi P, Patel N, Agarwal R.Home blood pressures are of greater prognostic value than hemodialysis unit recordings [J].Clin J Am Soc Nephrol,2007,2(6):1228-1234.
[14]
Agarwal R, Peixoto A, Santos SF,et al.Pre and postdialysis blood pressure are imprecise estimates of interdialytic ambulatory blood pressure [J].Clin J Am Soc Nephrol,2006,1(3):389-398.
[15]
丁小强,余金波.血液透析患者高血压诊治新进展[J/CD].中华肾病研究电子杂志,2014,3(3):118-122.
[16]
季大玺. 维持性血液透析患者高血压治疗的对策[J].肾脏病与透析肾移植杂志,2007,16 (2):152-153.
[17]
郑法雷. 透析患者高血压的合理治疗[J].中国血液净化, 2010,9(2):59.
[18]
倪兆慧. 合理选择降压药物对改善透析患者预后的意义[J]. 中华高血压杂志, 2011,19(12):1120-1123.
[19]
Thai DJ, Lim TW, James MT,et al. Cardiovascular effects of angiotensin converting enzyme inhibition or angiotensin receptor blockade in hemodialysis:a meta-analysis[J].Clin J Am Soc Nephrol,2010,5(4):623-630.
[1] 靳茜雅, 黄晓松, 谭诚, 蒋琴, 侯昉, 李瑶悦, 徐冰, 贾红慧, 刘文英. 产前他克莫司治疗对先天性膈疝大鼠病理模型肺血管重构的影响[J]. 中华妇幼临床医学杂志(电子版), 2023, 19(04): 428-436.
[2] 李建美, 邓静娟, 杨倩. 两种术式联合治疗肝癌合并肝硬化门静脉高压的安全性及随访评价[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 41-44.
[3] 张其坤, 商福超, 李琪, 栗光明, 王孟龙. 联合脾切除对肝癌合并门静脉高压症患者根治性切除术后的生存获益分析[J]. 中华肝脏外科手术学电子杂志, 2023, 12(06): 613-618.
[4] 许语阳, 吕云福, 王葆春. 乙肝后肝硬化门静脉高压症脾肿大外科治疗进展[J]. 中华肝脏外科手术学电子杂志, 2023, 12(04): 469-473.
[5] 赫嵘, 贾哲, 张珂, 李代京, 张萌, 蒋力. 基于PSM分析腹腔镜肝切除联合Hassab术治疗合并门静脉高压症肝癌疗效[J]. 中华肝脏外科手术学电子杂志, 2023, 12(04): 376-383.
[6] 杨林青, 任松, 纪泛扑, 张健, 蒋安, 张丽, 安鹏, 王林, 李宗芳. 揿针疗法对门静脉高压症脾切除断流术后胃肠功能的调节作用[J]. 中华肝脏外科手术学电子杂志, 2023, 12(03): 322-326.
[7] 杨静, 顾红叶, 赵莹莹, 孙梦霞, 查园园, 王琪. 老年血液透析患者短期死亡的影响因素及列线图预测模型的预测作用[J]. 中华肾病研究电子杂志, 2023, 12(05): 254-259.
[8] 王珊, 马清, 姚兰, 杨华昱. 老年维持性血透患者叶酸治疗与miR-150-5p血清水平的相关性研究[J]. 中华肾病研究电子杂志, 2023, 12(03): 139-144.
[9] 任国华, 杜晓晓, 洪善玲, 邵帅. 妊娠期高血压并发急性肾损伤患者血清白细胞介素-22、硫化氢及护骨素水平的变化与意义[J]. 中华肾病研究电子杂志, 2023, 12(03): 150-155.
[10] 李晓晨, 乔晞. 血液透析患者的血压靶目标值研究进展[J]. 中华肾病研究电子杂志, 2023, 12(03): 168-171.
[11] 运陌, 李茂芳, 王浩, 刘东远. 微创穿刺引流联合吡拉西坦、乌拉地尔治疗基底节区高血压性脑出血的临床研究[J]. 中华脑科疾病与康复杂志(电子版), 2023, 13(05): 278-285.
[12] 刘政委, 仪立志, 尹夕龙, 孔文龙, 纠智松, 张文源. 锥颅血肿外引流与神经内镜手术治疗老年基底节区高血压性脑出血的疗效分析[J]. 中华脑科疾病与康复杂志(电子版), 2023, 13(05): 299-303.
[13] 许秀兰, 朱建建. 血压变异性与伴H型高血压的急性脑梗死患者预后不良的临床关系分析[J]. 中华脑科疾病与康复杂志(电子版), 2023, 13(04): 199-204.
[14] 周加军, 余永武, 周涵, 张凌. 358例继发性甲状旁腺功能亢进症患者异位甲状旁腺的检出及分布情况分析[J]. 中华临床医师杂志(电子版), 2023, 17(04): 381-385.
[15] 张赟辉, 罗军, 刘栗丽, 汪宏, 耿克明. 腹膜透析与血液透析对老年终末期肾病患者营养状况及炎症反应的影响[J]. 中华临床医师杂志(电子版), 2023, 17(04): 419-423.
阅读次数
全文


摘要